Literature DB >> 5810074

The metabolic fate of DL(7-3H)isoprenaline in man and dog.

C D Morgan, M Sandler, D S Davies, M Conolly, J W Paterson, C T Dollery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5810074      PMCID： PMC1184819          DOI： 10.1042/bj1140008pa

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  2 in total

Review 1.  The release and fate of vaso-active hormones in the circulation.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

2.  Absorption and elimination profile of isoproterenol. 3. The metabolic fate of dl-isoproterenol-7-3H in the dog.

Authors:  W D Conway; H Minatoya; A M Lands; J M Shekosky
Journal:  J Pharm Sci       Date:  1968-07       Impact factor: 3.534
  2 in total
  3 in total

1.  Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog.

Authors:  N Himori; N Taira
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

2.  The fate of (3H)salbutamol in man.

Authors:  M E Evans; A J Richards; S R Walker; J W Patterson
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

3.  Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

Authors:  M E Conolly; D S Davies; C T Dollery; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.